Drugs / HCP0605
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04252872 | Aug → Nov 2015 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 1 | NCT04039724 | Feb → May 2015 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HCP0605 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04039724 ↗ |
| Route | Oral | “oral single dose” NCT04252872 ↗ |